CVRdatabase
Menu

Sanofi A/S

Public limited companyCVR 19064301København ØActive

Sanofi A/S is a public limited company, based in København Ø, active in wholesale of pharmaceutical goods and nursing supplies, founded in 1996. Net profit fell 19% from 2024 to 2025, ending at DKK 5m. With 88 employees, the company is about 10 times larger than the industry median. Gross profit is higher than that of 88% of the companies in the industry in the database.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 442.3m−2.3% vs. 2024
Net profitDKK 5m−18.9% vs. 2024
EquityDKK 58.7m+9.4% vs. 2024
Employees88latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 6% (2024 → 2025), to DKK 100.9m.
  • Revenue fell 2% (2024 → 2025), to DKK 442.3m.
  • Net profit fell 19% (2024 → 2025), to DKK 5m.
  • Equity rose 9% (2024 → 2025), to DKK 58.7m.

Employees

  • 4 more employees than a year earlier: 88 (08/2026) against 84 (08/2025).

Management and owners, last 24 months

  • New in management: Birgitte Fyhn (chair of the board, 25/11/2024), Odd Arne Gabriel Johannessen (board member, 04/03/2025) and Hao Zheng (board member, 04/03/2025) (+1).
  • Stepped down: Kirstin Jagd (chair of the board, 25/11/2024), Peter Wester Oldenziel (board member, 04/03/2025) and Daniel Andreas Sandgren (board member, 04/03/2025) (+1).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60mDKK 70mDKK 80m202020212022202320242025
EquityNet profit
Financial figures for Sanofi A/S
202020212022202320242025Change
Revenue563,450591,149530,879527,584452,617442,343−2.3%
Gross profit204,343135,675114,996102,537107,095100,902−5.8%
Operating profit (EBIT)86,90034,43720,6106,9859,5658,361−12.6%
Profit before tax87,47831,97519,2665,6778,8967,132−19.8%
Net profit67,21521,98215,9193,6976,2175,043−18.9%
Total assets225,760223,188179,873166,242192,036232,819+21.2%
Equity77,17569,31743,70647,40353,62058,663+9.4%
Liabilities148,585153,871136,167118,839138,416174,156+25.8%
Cash and cash equivalents6,3058,7492947,3407956,323+71,194.9%
Average number of employees1008685838178,000+96,196.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 50mDKK 100mDKK 150mDKK 200m202020212022202320242025
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Sanofi A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202530/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202407/07/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202301/07/2024The companyPDFXBRL
202201/01/2022 – 31/12/202207/07/2023The companyPDFXBRL
202101/01/2021 – 31/12/202108/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202030/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02040608010009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 100.9mNo. 29 of 232
Better than 88% of the companies in the industry
EquityDKK 58.7mNo. 40 of 232
Better than 83% of the companies in the industry
Number of employees88No. 3 of 232
Better than 99% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 654of 4,412
Better than 85%
No. 1,075of 4,466
Better than 76%
Same industry and 50–199 employees30 companies in the comparison
No. 21of 30
Better than 31%
No. 17of 30
Better than 45%
Companies that are at least 30 years old10,276 companies in the comparison
No. 834of 10,152
Better than 92%
No. 1,817of 10,275
Better than 82%
All companies of type A/S18,025 companies in the comparison
No. 1,560of 17,786
Better than 91%
No. 3,247of 18,024
Better than 82%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. Sanofi A/SDKK 100.9m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. Sanofi A/SDKK 5m
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. Sanofi A/SDKK 58.7m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. Sanofi A/S88
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Sanofi-Aventis Participations100%
Sanofi A/S

Management

4 active registrations

Executive management

Executive management at Sanofi A/S
NameRoleAppointed
Odd Arne Gabriel JohannessenDirector06/03/2025

Board of directors

Board of directors at Sanofi A/S
NameRoleAppointed
Birgitte FyhnChair of the board25/11/2024
Odd Arne Gabriel JohannessenBoard member04/03/2025
Hao ZhengBoard member04/03/2025
Founders
VX 10.312 ApS
Former management (35)
Former management at Sanofi A/S
NameRoleAppointedResigned
Hans Christian GalstBoard member15/01/199623/04/1996
Ulf Svejgaard PoulsenChair of the board15/01/199623/04/1996
Per Emil Hasselbalch StakemannBoard member15/01/199623/04/1996
Per Emil Hasselbalch StakemannDirector15/01/199623/04/1996
Per Aage Gregor ChristensenBoard member23/04/199626/11/2004
Ursula Sara Barbro TengelinBoard member23/04/199630/05/2000
Ursula Sara Barbro TengelinDirector23/04/199616/12/1999
Philip Oswald BurchardChair of the board23/04/199630/05/2000
Per Aage Gregor ChristensenDirector16/12/199926/11/2004
Flemming LauritzenBoard member30/05/200009/11/2012
Roger HemingwayBoard member30/05/200007/05/2001
Seppo Antero SilanderChair of the board07/05/200126/11/2004
Joannes Victor Maria HendrickxBoard member26/11/200402/01/2006
Joannes Victor Maria HendrickxCEO26/11/200402/01/2006
Peter Antoon Hugo GuenterChair of the board26/11/200418/04/2006
Karen Lykke SørensenCEO02/01/200601/09/2008
Jean-Marie ArgelesChair of the board18/04/200601/01/2007
Colette MutschlerChair of the board01/01/200701/09/2008
Karen Lykke SørensenChair of the board01/09/200801/10/2009
Lasse Richter PetersenBoard member01/09/200813/04/2016
Lasse Richter PetersenCEO01/09/200813/04/2016
Jean Laurent DoussetChair of the board01/10/200930/05/2012
Stéphane Marie Jean Amédée MalphettesBoard member31/05/201115/11/2011
Minna Satu Marketta KallioChair of the board31/05/201213/04/2016
Kirstin JagdBoard member09/11/201212/04/2016
Kirstin JagdChair of the board13/04/201625/11/2024
Rasmus VillemoesBoard member13/04/201602/04/2024
Charlotte Søby VestergaardBoard member13/04/201614/02/2019
Charlotte Søby VestergaardCEO13/04/201607/09/2018
Rasmus VillemoesCEO07/09/201802/04/2024
Peter Wester OldenzielBoard member14/02/201904/03/2025
Fiona Sylvie Simone de BouvereBoard member02/04/202402/09/2024
Fiona Sylvie Simone de BouvereDirector02/04/202402/09/2024
Daniel Andreas SandgrenBoard member02/09/202404/03/2025
Daniel Andreas SandgrenDirector02/09/202406/03/2025

Signing rule: Selskabet tegnes af den samlede bestyrelse, af et medlem af bestyrelsen eller af en direktør.

Address and production units

1 active production units

Lyngbyvej 2
2100 København Ø

København Municipality · Postcode 2100

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
Sanofi A/SLyngbyvej 2, 2100 København Ø881003781922

Purpose

Selskabets formål er at drive handel og produktion af farmaceutiske produkter og alle aktiviteter, der relaterer sig til research, udvikling, produktion, udnyttelse og marketing af bio-farmaceutiske og farmaceutiske produkter, inklusive vacciner, serummer, immummodulatoer og produkter afledt fra bio-teknologi og højteknologi beregnet til humanmedicinske lægemidler.

The purpose is quoted from the register in Danish.

Changes year by year

96 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20257 changesaccounts 1 · management 6
  • Annual report for 2024 published
  • Odd Arne Gabriel Johannessen appointed director
  • Daniel Andreas Sandgren stepped down as director
  • Hao Zheng appointed board member
  • Odd Arne Gabriel Johannessen appointed board member
  • Daniel Andreas Sandgren stepped down as board member
  • Peter Wester Oldenziel stepped down as board member
202411 changesmanagement 10 · accounts 1
  • Birgitte Fyhn appointed chair of the board
  • Kirstin Jagd stepped down as chair of the board
  • Daniel Andreas Sandgren appointed board member
  • Daniel Andreas Sandgren appointed director
  • Fiona Sylvie Simone de Bouvere stepped down as director
  • Fiona Sylvie Simone de Bouvere stepped down as board member
  • Annual report for 2023 published
  • Fiona Sylvie Simone de Bouvere appointed director
  • Fiona Sylvie Simone de Bouvere appointed board member
  • Rasmus Villemoes stepped down as ceo
  • Rasmus Villemoes stepped down as board member
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20192 changesmanagement 2
  • Peter Wester Oldenziel appointed board member
  • Charlotte Søby Vestergaard stepped down as board member
20186 changesaddress 3 · management 2 · name 1
  • Moved to Lyngbyvej 2, 2100 København Ø
  • Moved to Slotsmarken 13, 2970 Hørsholm
  • Moved to Lyngbyvej 2, 2100 København Ø
  • Rasmus Villemoes appointed ceo
  • Charlotte Søby Vestergaard stepped down as ceo
  • Name changed from SANOFI-AVENTIS DENMARK A/S to Sanofi A/S
20168 changesmanagement 8
  • Charlotte Søby Vestergaard appointed ceo
  • Charlotte Søby Vestergaard appointed board member
  • Rasmus Villemoes appointed board member
  • Kirstin Jagd appointed chair of the board
  • Minna Satu Marketta Kallio stepped down as chair of the board
  • Lasse Richter Petersen stepped down as board member
  • Lasse Richter Petersen stepped down as ceo
  • Kirstin Jagd stepped down as board member
20133 changesownership 1 · capital 1 · merger 1
  • Sanofi-Aventis Participations registered as owner (100%)
  • Share capital changed from 6,597,300 DKK to 7,000,000 DKK
  • Merger registered in CVR
20124 changesmanagement 4
  • Kirstin Jagd appointed board member
  • Flemming Lauritzen stepped down as board member
  • Minna Satu Marketta Kallio appointed chair of the board
  • Jean Laurent Dousset stepped down as chair of the board
20112 changesmanagement 2
  • Stéphane Marie Jean Amédée Malphettes stepped down as board member
  • Stéphane Marie Jean Amédée Malphettes appointed board member
20092 changesmanagement 2
  • Jean Laurent Dousset appointed chair of the board
  • Karen Lykke Sørensen stepped down as chair of the board
20085 changesmanagement 5
  • Lasse Richter Petersen appointed board member
  • Karen Lykke Sørensen appointed chair of the board
  • Lasse Richter Petersen appointed ceo
  • Colette Mutschler stepped down as chair of the board
  • Karen Lykke Sørensen stepped down as ceo
20072 changesmanagement 2
  • Colette Mutschler appointed chair of the board
  • Jean-Marie Argeles stepped down as chair of the board
20068 changesname 1 · capital 1 · merger 1 · management 5
  • Name changed from AVENTIS PHARMA A/S to SANOFI-AVENTIS DENMARK A/S
  • Share capital changed from 6,500,000 DKK to 6,597,300 DKK
  • Merger registered in CVR
  • Jean-Marie Argeles appointed chair of the board
  • Peter Antoon Hugo Guenter stepped down as chair of the board
  • Karen Lykke Sørensen appointed ceo
  • Joannes Victor Maria Hendrickx stepped down as ceo
  • Joannes Victor Maria Hendrickx stepped down as board member
20046 changesmanagement 6
  • Peter Antoon Hugo Guenter appointed chair of the board
  • Joannes Victor Maria Hendrickx appointed ceo
  • Joannes Victor Maria Hendrickx appointed board member
  • Seppo Antero Silander stepped down as chair of the board
  • Per Aage Gregor Christensen stepped down as director
  • Per Aage Gregor Christensen stepped down as board member
20031 changemerger 1
  • Merger registered in CVR
20013 changesaddress 1 · management 2
  • Moved to Slotsmarken 13, 2970 Hørsholm
  • Seppo Antero Silander appointed chair of the board
  • Roger Hemingway stepped down as board member
20005 changesname 1 · management 4
  • Name changed from HOECHST MARION ROUSSEL A/S to AVENTIS PHARMA A/S
  • Flemming Lauritzen appointed board member
  • Roger Hemingway appointed board member
  • Ursula Sara Barbro Tengelin stepped down as board member
  • Philip Oswald Burchard stepped down as chair of the board
19992 changesmanagement 2
  • Per Aage Gregor Christensen appointed director
  • Ursula Sara Barbro Tengelin stepped down as director
19981 changecapital 1
  • Share capital changed from 500,000 DKK to 6,500,000 DKK
199614 changesname 1 · management 12 · founded 1
  • Name changed from A/S PSE NR. 4962 to HOECHST MARION ROUSSEL A/S
  • Ursula Sara Barbro Tengelin appointed board member
  • Philip Oswald Burchard appointed chair of the board
  • Ursula Sara Barbro Tengelin appointed director
  • Per Aage Gregor Christensen appointed board member
  • Ulf Svejgaard Poulsen stepped down as chair of the board
  • Per Emil Hasselbalch Stakemann stepped down as director
  • Per Emil Hasselbalch Stakemann stepped down as board member
  • Hans Christian Galst stepped down as board member
  • Registered as A/S PSE NR. 4962
  • Ulf Svejgaard Poulsen appointed chair of the board
  • Per Emil Hasselbalch Stakemann appointed director
  • Per Emil Hasselbalch Stakemann appointed board member
  • Hans Christian Galst appointed board member

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction